Formosa Pharmaceuticals, Inc. (TPE:6838)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
23.95
-0.75 (-3.04%)
Sep 8, 2026, 1:30 PM CST

Formosa Pharmaceuticals Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3,7293,9865,6546,7005,9213,390
Market Cap Growth
-21.21%-29.51%-15.62%13.17%74.66%-
Enterprise Value
2,5382,4994,0175,4725,8002,937
Last Close Price
24.7026.4037.4549.9550.5932.95

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
70.92419.7839.44214.954502.47118.82
PB Ratio
2.722.743.655.8812.678.62
P/TBV Ratio
4.014.014.698.77105.56-

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
48.26263.2128.02175.534410.71102.95

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.020.020.020.030.020.01
Net Debt / Equity Ratio
-0.87-0.97-1.05-1.04-0.89-0.52
Net Debt / EBITDA Ratio
9.5511.0211.574.791.200.60
Net Debt / FCF Ratio
4.0513.3911.925.991.200.62
Asset Turnover
0.030.010.080.020.000.05
Inventory Turnover
5.153.14----
Quick Ratio
13.118.828.574.896.2611.55
Current Ratio
14.639.118.734.996.5612.15
Return on Equity (ROE)
-12.92%-5.56%-14.94%-40.04%-94.39%-135.15%
Return on Assets (ROA)
-5.22%-5.10%-5.72%-13.58%-30.45%-41.28%
Return on Capital Employed (ROCE)
-9.30%-9.00%-9.20%-19.30%-47.20%-56.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-5.10%-2.10%-3.55%-4.81%-6.86%-11.83%
FCF Yield
-7.90%-2.65%-2.40%-2.96%-5.85%-9.78%
Buyback Yield / Dilution
-1.17%-7.22%-13.48%-18.00%-13.70%-31.19%